Lv5
806 积分 2024-05-17 加入
Dual-target gene therapy in Parkinson’s disease: a multicenter phase 1 trial
26天前
已完结
[Chinese expert consensus on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors]
1个月前
已完结
JAK inhibitor selectivity: new opportunities, better drugs?
1个月前
已完结
Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions—Part 1
1个月前
已关闭
The race to reset autoimmune diseases
2个月前
已完结
Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment
3个月前
已完结
Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis
3个月前
已完结
The Current Status of Radionuclide Tumor Targeting Diagnosis and Therapy Based on FAP-2286: From Preclinical Studies to Clinical Application
4个月前
已完结
Discovery of Imidazo[1,2-b]pyridazine Derivatives as Potent and Highly Selective Irreversible Bruton’s Tyrosine Kinase (BTK) Inhibitors
4个月前
已完结
Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors
5个月前
已完结
皖公网安备34019202002308
